Fiche centre
The 2nd Affiliated Hospital of Harbin Medical University
Harbin — China
Essais liés3clinical trials
VilleHarbinlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06154395
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Extract of Ginkgo Biloba Leaves Tablets 240 mg (2 x 40 mg, t.i.d.) | Accident vasculaire cérébral | Phase 4 | NCT07220538 | GiCIIS — A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment | ACTIVE_NOT_RECRUITING |
| OCT-guided PCI | Maladie coronarienne | Non applicable | NCT06154395 | Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction | RECRUITING |
| SG301 SC Injection | Lupus | Phase 2 | NCT07447986 | To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus | RECRUITING |